Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-26 @ 1:27 AM
NCT ID:
NCT01664533
Group ID:
EG000
Title:
Erlotinib
Description:
Selection of the dose of erlotinib most suitable for each participant was left to the discretion of the physician, guided by the recommendation in the Summary of Product Characteristics. The recommended daily oral dose of erlotinib is 150 mg.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
17
Serious Number At Risk:
57
Other Number Affected:
51
Other Number At Risk:
57
Study:
NCT01664533
Results Section:
NCT01664533
Adverse Events Module:
NCT01664533